Potentiation of temozolomide activity against glioblastoma cells by aromatase inhibitor letrozole

被引：0
|
作者：
Aniruddha S. Karve
Janki M. Desai
Nimita Dave
Trisha M. Wise-Draper
Gary A. Gudelsky
Timothy N. Phoenix
Biplab DasGupta
Soma Sengupta
David R. Plas
Pankaj B. Desai
机构：
[1] University of Cincinnati,Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy
[2] University of Cincinnati College of Medicine,Division of Hematology/Oncology
[3] Cincinnati Children’s Hospital,Division of Oncology
[4] University of Cincinnati College of Medicine,Department of Neurology and Rehabilitation Medicine
[5] University of Cincinnati College of Medicine,Department of Cancer Biology
[6] Nimbus Therapeutics,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2022年 / 90卷
关键词：
Glioblastoma; Temozolomide; Drug-resistance; Aromatase inhibitors; Letrozole; Synergism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：345 / 356
页数：11
相关论文
共 50 条
  • [21] The effects of an aromatase inhibitor (Letrozole) on hormone and sperm production in the stallion
    Stein, TA
    Ball, BA
    Conley, AJ
    Bhatnagar, AS
    Roser, JF
    THERIOGENOLOGY, 2002, 58 (2-4) : 381 - 383
  • [22] Evaluation of Thymidine Phosphorylase Inhibitors in Glioblastoma and Their Capacity for Temozolomide Potentiation
    Warfield, Becka M.
    Matheson, Christopher J.
    McArthur, Debbie G.
    Backos, Donald S.
    Reigan, Philip
    ACS CHEMICAL NEUROSCIENCE, 2021, 12 (18): : 3477 - 3486
  • [23] Does inhibition of aromatase by the specific inhibitor letrozole radiosensitize human breast cancer cells in vitro?
    Schmid-Bielenberg, D.
    Ohneseit, P. A.
    Krebiehl, G.
    Rodemann, H. P.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 : 79 - 79
  • [24] Effects of the steroidal aromatase inhibitor exemestane and the nonsteroidal aromatase inhibitor letrozole on bone and lipid metabolism in ovariectomized rats
    Goss, PE
    Qi, S
    Cheung, AM
    Hu, HQ
    Mendes, M
    Pritzker, KPH
    CLINICAL CANCER RESEARCH, 2004, 10 (17) : 5717 - 5723
  • [25] Regression of chronic lymphocytic leukemia with aromatase inhibitor-letrozole?
    Paydas, Semra
    LEUKEMIA RESEARCH, 2009, 33 (04) : 566 - 567
  • [26] Sensitivity to the Aromatase Inhibitor Letrozole Is Prolonged After a "Break" in Treatment
    Sabnis, Gauri
    Goloubeva, Olga
    Gilani, Rabia
    Macedo, Luciana
    Brodie, Angela
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (01) : 46 - 56
  • [27] THE AROMATASE INHIBITOR, LETROZOLE: A NOVEL TREATMENT FOR ECTOPIC PREGNANCY.
    Mitwally, Mohamed F.
    Hozayen, Walaa G.
    Hassanin, Kamel M. A.
    Abdalla, Kamal A.
    Abdalla, Noha K.
    FERTILITY AND STERILITY, 2019, 112 (03) : E81 - E81
  • [28] Testis morphology in rats chronically treated with letrozole, an aromatase inhibitor
    Kondarewicz, Anna
    Kolasa, Agnieszka
    Zawislak, Bartosz
    Baranowska-Bosiacka, Irena
    Marchlewicz, Mariola
    Wenda-Rozewicka, Lidia
    Wiszniewska, Barbara
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2011, 49 (04) : 677 - 684
  • [29] Coadministrating Luteolin Minimizes the Side Effects of the Aromatase Inhibitor Letrozole
    Li, Fengjuan
    Wong, Tsz Yan
    Lin, Shu-mei
    Chow, Simon
    Cheung, Wing-hoi
    Chan, Franky L.
    Chen, Shiuan
    Leung, Lai K.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2014, 351 (02): : 270 - 277
  • [30] A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cells
    Meryem Bektas
    Stewart P. Johnson
    William E. Poe
    Darell D. Bigner
    Henry S. Friedman
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 1053 - 1058
12345